OAIP opened in July 2024, and it offers regulatory mitigation agreements to participants in its Learning Lab so that AI applications can advance more efficiently — with state oversight in place. This program is designed to clear regulatory hurdles and provide support for Utah companies using AI. It allows them to thrive and innovate without unnecessary restrictions while providing reasonable consumer protections.
For example, OAIP already initiated a regulatory mitigation agreement with ElizaChat to help officials explore the role of AI in mental health. OAIP Director Zach Boyd told Government Technology in 2025 that he expected to expand work in this area as other companies had expressed interest, saying that OAIP was “just getting started” at that time.
OAIP on Tuesday announced a new agreement of this nature with Doctronic, an AI-native health platform, as a way to make prescription renewals more efficient. Prescription renewals account for roughly 80 percent of medication activity, per the announcement, and officials are exploring how AI could reduce the delays people experience in accessing medications they rely on.
OAIP’s focus is not on internal AI use within state government, as Utah CIO Alan Fuller said previously — but on AI’s broader impact to society and answering questions related to accountability.
With this new partnership, Doctronic will legally prescribe routine refills with its autonomous AI platform, operating within Utah’s regulatory sandbox framework. This means that OAIP will be evaluating the pilot, specifically assessing safety protocols, patient experience and effectiveness. Medication refill timelines and adherence, patient satisfaction, safety and cost outcomes, and workflow efficiency will be tracked.
OAIP’s announcement describes the agreement as the “first state-approved program in the country” enabling the participation of an AI system in the medical decision-making process for prescription renewals.
“By creating a supportive environment for companies like Doctronic AI, the Utah Office of Artificial Intelligence Policy provides the certainty necessary for them to develop impactful solutions while prioritizing the well-being of Utahns,” Margaret Woolley Busse, executive director of the Utah Department of Commerce, said in a statement.
In addition to ElizaChat and Doctronic, OAIP partnered with Dentacor in May to explore the use of AI in dental care. These agreements allow officials to explore the impacts of AI deployment in the health-care sector, with regular communication and data sharing with the state about safety and compliance.
Utah is not the only state supporting AI use case exploration and testing with sandbox models. Arizona has developed sandbox environments for agencies to experiment safely with AI in partnership with vendors. Massachusetts’ sandbox allows AI to advance with “terms and conditions” in place, CIO Jason Snyder said last year. As of fall 2025, New Jersey’s AI sandbox was actively being used by about 20 percent of state workers, Chief Innovation Officer Dave Cole said.
Findings from OAIP’s partnership with Doctronic will be shared publicly with the goal of shaping AI policy at the state — and federal — level.
“This is a major milestone to demonstrate how AI can improve access to care and health outcomes,” Matt Pavelle, co-CEO of Doctronic, said in a statement. “We hope other states follow Utah’s lead.”
